Evaluation of MUC1 and P53 expressions in noninvasive papillary urothelial neoplasms of bladder, their relationship with tumor grade and role in the differential diagnosis

Purpose: The aim of this study was to investigate the usability of MUC1 and p53 for differential diagnosis of noninvasive papillary urothelial neoplasias, especially for distinguishing papillary urothelial neoplasm of low malignant potential (PUNLMP) from low-grade papillary urothelial carcinoma (LG...

Full description

Saved in:
Bibliographic Details
Main Authors: Esin Kaymaz (Author), Elif Ozer (Author), Hatice Unverdi (Author), Sema Hucumenoglu (Author)
Format: Book
Published: Wolters Kluwer Medknow Publications, 2017-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_7cacf2ea3f9b49b096d3d5e6da7b9b99
042 |a dc 
100 1 0 |a Esin Kaymaz  |e author 
700 1 0 |a Elif Ozer  |e author 
700 1 0 |a Hatice Unverdi  |e author 
700 1 0 |a Sema Hucumenoglu  |e author 
245 0 0 |a Evaluation of MUC1 and P53 expressions in noninvasive papillary urothelial neoplasms of bladder, their relationship with tumor grade and role in the differential diagnosis 
260 |b Wolters Kluwer Medknow Publications,   |c 2017-01-01T00:00:00Z. 
500 |a 0377-4929 
500 |a 10.4103/IJPM.IJPM_204_16 
520 |a Purpose: The aim of this study was to investigate the usability of MUC1 and p53 for differential diagnosis of noninvasive papillary urothelial neoplasias, especially for distinguishing papillary urothelial neoplasm of low malignant potential (PUNLMP) from low-grade papillary urothelial carcinoma (LGPUC) when the histologic signs are not obvious. Materials and Methods: Seventeen biopsy specimens of the patients with PUNLMP, 20 with LGPUC and 13 with high-grade papillary urothelial carcinoma (HGPUC) were stained for MUC1 and p53 protein by immunohistochemical methods. Histological grading was performed according to an algorithm, which allows histological parameters used in 2004 WHO/ISUP 1998. Results: We had obvious statistical difference for aberrant expression pattern of MUC1 between PUNLMP and LGPUC-HGPUC (P = 0.007). Positivity of MUC1 expression in cytoplasm of basal cells was more observed in HGPUC and LGPUC, whereas PUNLMP was more often showing apical and superficial positivity of MUC1 expression (P = 0.001 and 0.011). Nuclear p53 protein in HGPUC was obviously more frequent than that in LGPUC and PUNLMP (P < 0.001). Measures showed statistical difference among aberrant MUC1 expression, p53 overexpression, and tumor grade (P < 0.001). Conclusions: MUC1 and p53 may be helpful immunohistochemical markers for distinguishing PUNLMP from LGPUC and HGPUC, when the histologic signs are not obvious. 
546 |a EN 
690 |a Bladder neoplasm 
690 |a MUC1 
690 |a p53 
690 |a Pathology 
690 |a RB1-214 
690 |a Microbiology 
690 |a QR1-502 
655 7 |a article  |2 local 
786 0 |n Indian Journal of Pathology and Microbiology, Vol 60, Iss 4, Pp 510-514 (2017) 
787 0 |n http://www.ijpmonline.org/article.asp?issn=0377-4929;year=2017;volume=60;issue=4;spage=510;epage=514;aulast=Kaymaz 
787 0 |n https://doaj.org/toc/0377-4929 
856 4 1 |u https://doaj.org/article/7cacf2ea3f9b49b096d3d5e6da7b9b99  |z Connect to this object online.